Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,114 public trials 2,036 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India

NCT03476655

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations: Apollo Hospitals International Limited Ahmedabad, India

Healthcare Global (HCG) Hospital Bangalore, India

Fortis Memorial Research Institute Gurgaon, India

Basavatarakam Indo-American Hospital Hyderabad, India

View Trial Details

Completed

Siltuximab for the Prevention of CAR T Cell Related Cytokine Release Syndrome in Patients With CD19 Positive Non-Hodgkin Lymphoma

NCT05665725

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease

NCT05328115

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +18 more
Locations: Clinical Research Services Turku -CRST Oy Turku, Finland

View Trial Details

Completed

Virtual Remote Physiological Monitoring Program of Children With Heart Disease

NCT05034354

Conditions: Biventricular Congestive Heart Failure, Cardiovascular Abnormalities, Cardiovascular Diseases, +22 more
Locations: University of Alberta Edmonton, Alberta, Canada

View Trial Details

Completed

Bendamustine and Melphalan in Myeloma

NCT03187223

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Department for Medical Oncology University Hospital/Inselspital Bern, Switzerland

View Trial Details

Completed

Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System

NCT03495960

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Aarhus University Hospital Aarhus, Denmark

Odense University Hospital Odense, Denmark

Oulu University Hospital Oulu, Finland

Tampere University Hospital Tampere, Finland

View all 34 locations

View Trial Details

Completed

Identification of Autoantigens in EGPA and Severe Eosinophilic Asthma

NCT04671446

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +29 more
Locations: Barts Health NHS Trust, Dept of Rheumatology, Mile End Hospital London, United Kingdom

Barts Health NHS Trust, Dept of Respiratory Medicine, St Bartholomew's Hospital London, United Kingdom

View Trial Details

Completed

Clarithromycin + Lenalidomide Combination: a Full Oral Treatment for Patients With Relapsed/Refractory Extranodal Marginal Zone Lymphoma

NCT03031483

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Medical University of Vienna Vienna, Austria

A.O. Spedali Civili di Brescia Brescia, Italy

Azienda Ospedaliera Papardo Messina, Italy

IRCCS Ospedale San Raffaele Milan, Italy

View Trial Details

Completed

For Grade I and II Knee Meniscal Injuries Patients ,Glucosamine, Chondroitin and Some Herbs Extract Phonophoresis Will Be Used (A) Versus Placebo(B)

NCT06798428

Conditions: Grade I and II Knee Meniscal Injuries, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Al ahrar teaching hospital Zagazig, Sharqia Province, Egypt

View Trial Details

Completed

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

NCT04466098

Conditions: ARDS (Moderate or Severe), Acute Respiratory Distress Syndrome, COVID-19, +30 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions